albumin-bound valrubicin nanoparticles (LipoMedics)

N/A

Report date: 2025/03/17 20:00:36

Base Information

Drug Namealbumin-bound valrubicin nanoparticles (LipoMedics)
Drug Alias NameN/A
ClassificationBiologics
Mechanisms of ActionSerum albumin modulatorsDNA intercalators
TargetsDNASerum albumin
Therapy Area/IndicationsSolid tumours
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesLipoMedics Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesLipoMedics IncAutotelic
Active IndicationsN/A
Inactive IndicationsSolid tumours

Other Information

ATC CodeN/A
Related LinksN/A